123 related articles for article (PubMed ID: 12373683)
1. [Influence of factors not related with HIV infection on neuropsychological performance of HIV-seropositive patients].
Vázquez-Justo E; Rodríguez-Alvarez M
Rev Neurol; 2002 Sep 1-15; 35(5):474-80. PubMed ID: 12373683
[TBL] [Abstract][Full Text] [Related]
2. [Influence of infection related factors on neuropsychological performance of HIV seropositive subjects].
Rodríguez Alvarez M; Vázquez-Justo E
Neurologia; 2002; 17(6):328-36. PubMed ID: 12084360
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological impairment and the natural history of HIV-1 infection in Spanish subjects.
Rodríguez Alvarez M; Faílde Garrido JM; Simón López MA
Funct Neurol; 2007; 22(3):165-70. PubMed ID: 17925167
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and drug use: influence on cognitive function.
Grassi MP; Clerici F; Perin C; Zocchetti C; Borella M; Cargnel A; Mangoni A
AIDS; 1995 Feb; 9(2):165-70. PubMed ID: 7718187
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
[TBL] [Abstract][Full Text] [Related]
6. [Study of HIV-related neuropsychological impairment: a review of methodological aspects].
RodríIguez Alvarez M; Rodriguez Salgado D
Actas Esp Psiquiatr; 2003; 31(2):79-84. PubMed ID: 12677472
[TBL] [Abstract][Full Text] [Related]
7. [Neuropsychological impairment in human immunodeficiency virus-positive children].
Millana-Cuevas LC; Portellano JA; Martinez-Arias R
Rev Neurol; 2007 Mar 16-31; 44(6):366-74. PubMed ID: 17385174
[TBL] [Abstract][Full Text] [Related]
8. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection.
Trépanier LL; Rourke SB; Bayoumi AM; Halman MH; Krzyzanowski S; Power C
J Clin Exp Neuropsychol; 2005 Jan; 27(1):1-15. PubMed ID: 15814439
[TBL] [Abstract][Full Text] [Related]
9. [Study of neurological and cognitive changes in patients in stage III and initial phases of stage IV of infection by human immunodeficiency virus type 1].
Abós J; Graus F; Marqués G; Alom J; Miró JM; Mallolas J; Tolosa E
Med Clin (Barc); 1992 Jan; 98(2):41-4. PubMed ID: 1545618
[TBL] [Abstract][Full Text] [Related]
10. Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users.
Waldrop-Valverde D; Ownby RL; Kumar M
Psychiatry Clin Neurosci; 2005 Aug; 59(4):372-8. PubMed ID: 16048441
[TBL] [Abstract][Full Text] [Related]
11. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
[TBL] [Abstract][Full Text] [Related]
12. Influence of depressed mood on neuropsychologic performance in HIV-seropositive drug users.
Vázquez-Justo E; Rodríguez Alvarez M; Ferraces Otero MJ
Psychiatry Clin Neurosci; 2003 Jun; 57(3):251-8. PubMed ID: 12753563
[TBL] [Abstract][Full Text] [Related]
13. Cognitive reserve during neuropsychological performance in HIV intravenous drug users.
Vázquez-Justo E; Blanco AP; Vergara-Moragues E; Gestoso CG; Pérez-García M
Appl Neuropsychol Adult; 2014; 21(4):288-96. PubMed ID: 25265310
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study.
Justice AC; McGinnis KA; Atkinson JH; Heaton RK; Young C; Sadek J; Madenwald T; Becker JT; Conigliaro J; Brown ST; Rimland D; Crystal S; Simberkoff M;
AIDS; 2004 Jan; 18 Suppl 1():S49-59. PubMed ID: 15075498
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
[TBL] [Abstract][Full Text] [Related]
16. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
[TBL] [Abstract][Full Text] [Related]
17. [Cognitive slowing in asymptomatic individuals who are seropositive for human immunodeficiency virus type 1].
Amador F; Mayor-Ríos J; del Castillo-Martín N
Rev Neurol; 2006 Feb 1-15; 42(3):132-6. PubMed ID: 16475133
[TBL] [Abstract][Full Text] [Related]
18. [Neurologic and neuropsychologic manifestations in asymptomatic HIV positive subjects. Results of the first year follow-up].
Amer G; Arranz P; Bayes R; Magallón M; Pastor I; Urrutia G
Arch Neurobiol (Madr); 1989; 52 Suppl 1():68-72. PubMed ID: 2637656
[TBL] [Abstract][Full Text] [Related]
19. [Mental disorders and neuropsychological impairment related to chronic use of cannabis].
Tziraki S
Rev Neurol; 2012 Jun; 54(12):750-60. PubMed ID: 22673951
[TBL] [Abstract][Full Text] [Related]
20. The HIV Dementia Scale: predictive power in mild dementia and HAART.
Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
